You searched for Parkinson's - Page 16 of 19

Best in Biotech 12 May 2023

Five latest advancements in Tourette’s syndrome research

…funding round last year. Closed-loop deep brain stimulation shows encouraging results as Tourette’s therapy Deep brain stimulation (DBS) has paved the way for transformative treatment approaches for Parkinson’s disease. Moreover,…

May 12, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 4 Jan 2018

A Crash Course in the Basics of Finance in Biotechnology

…might be switching from the first market approval of a CAR-T therapy to the latest strategy to protect crops from pests to a new anti-Parkinson’s drug. It can be hard…

January 4, 2018 - 5 minutesmins - By Alex Dale

News and Trends 13 Jul 2023

Gene therapy company EG 427 raises €18M

…or other neurodegenerative diseases such as multiple sclerosis or Parkinson’s disease. Pierre Denys, head of Urology department at R. Poincaré Hospital in Paris and co-founder of EG 427, said: “Neurogenic…

July 13, 2023 - 4 minutesmins - By Jim Cornall

danish biotech neurodegenerative alzheimers 1

News and Trends 20 Jul 2021

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

…treatments for Parkinson’s disease, multiple sclerosis, and frontotemporal dementia. Research in Alzheimer’s disease and in other neurodegenerative diseases has picked up in recent months, after a tough streak of more…

July 20, 2021 - 4 minutesmins - By Victor Kotsev

News and Trends 13 Jul 2022

Sanofi sells two portfolios of established products to Neuraxpharma

…across a large spectrum of diseases including depression, anxiety, psychosis, alcohol dependence, myasthenia gravis and Parkinson disease. The CNS portfolio notably includes Nozinan, Tranxene, Tiapridal, Dogmatil, Largactil. The pain and…

July 13, 2022 - 2 minutesmins - By Liza Laws

Interview 28 Oct 2022

Migraines: a new vaccine frontier beyond infectious diseases

…vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the convenience and affordability of vaccines, Vaxxinity’s synthetic…

October 28, 2022 - 7 minutesmins - By Omnia Ibrahim

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

…targeting neuroinflammation in Parkinson’s disease. Orna Therapeutics Founded: 2019 Focus area: Circular RNA therapies Lead candidate: In vivo CAR-T Orna Therapeutics is developing therapies using circular RNA, an alternative to…

July 4, 2025 - 15 minutesmins - By Jules Adam

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…loss in the brain. LMTX also inhibits the aggregation of TPD-43 (behavioral variant frontotemporal dementia), synuclein (Parkinson’s disease), and huntingtin proteins (Huntington’s disease). With 2016’s biggest fundraising round of €120M…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

Best in Biotech 2 May 2024

Eight monoclonal antibody biotechs making strides in the clinic

…BioArctic looks to counter is Parkinson’s disease. Its phase 1 candidate exidavenmab is a monoclonal antibody that binds to toxic forms of alpha-synuclein – a protein that can cause inflammation…

May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter

silk fibroin biomaterial stroke stem cells

News and Trends 19 Nov 2018

Silk Biomaterial Could Regenerate the Brain After a Stroke

…as Parkinson’s and Alzheimer’s, eye diseases like glaucoma and age-related macular degeneration, the repair of skin and tendons, and the treatment of incontinence and impotence caused by prostate surgery. Images…

November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Feb 2020

EU Project Set up to Fight Alzheimer’s Disease with Lasers

…some symptoms of Parkinson’s disease. Unlike these other techniques, the project aims to target specific brain networks, rather than individual brain regions or cells. “We are focused on the knowledge…

February 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Jan 2023

Ubiquigent and University of Glasgow to collaborate on drug discovery

…has been proposed as a therapeutic strategy for Parkinson’s disease (PD). Although numerous USP30-targeting compounds are reported in scientific literature, only one has been approved to enter clinical evaluation so…

January 24, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Five latest advancements in Tourette’s syndrome research

A Crash Course in the Basics of Finance in Biotechnology

Gene therapy company EG 427 raises €18M

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Sanofi sells two portfolios of established products to Neuraxpharma

Migraines: a new vaccine frontier beyond infectious diseases

14 biotech companies to know in the Boston area in 2025

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Eight monoclonal antibody biotechs making strides in the clinic

Silk Biomaterial Could Regenerate the Brain After a Stroke

EU Project Set up to Fight Alzheimer’s Disease with Lasers

Ubiquigent and University of Glasgow to collaborate on drug discovery

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!